Clariant (CLN) CMD 2024 summary
Event summary combining transcript, slides, and related documents.
CMD 2024 summary
3 Feb, 2026Strategic transformation and business model evolution
Streamlined portfolio to focus on specialty chemicals, increasing exposure to consumer markets and divesting non-core assets since 2021, with a customer-centric operating model and differentiated segment steering.
Reduced cost base with CHF 175 million in targeted savings by 2025, over 90% already achieved, and further CHF 80 million in savings planned by 2027.
New operating model since January 2023, reducing management layers, consolidating business units from five to three, and empowering regional leadership with full P&L accountability.
Enhanced employee engagement and customer satisfaction, with top quartile Net Promoter Scores and safety targets.
Increased focus on innovation and sustainability, leveraging megatrends such as decarbonization, health, and digitalization.
Growth strategy, innovation, and sustainability
Growth driven by global megatrends: health, wellness, sustainability, energy transition, digitalization, and decarbonization.
Innovation arenas—health and sustainability-conscious consumers, energy transition, and circularity—will generate over 70% of growth by 2027 and deliver ~1.5% market outgrowth p.a.
Over 80% of sales from sustainable products; phased out PFAS-containing and non-sustainable products; leading in greenhouse gas emissions intensity reduction.
Upgraded 2030 sustainability targets: 46% reduction in Scope 1 & 2, 28% in Scope 3 emissions, aligned with 1.5°C SBTi trajectory and Paris Agreement.
Digitalization and AI (Clarita) deployed across sales, R&D, and operations, with 36% of employees using AI tools and digital customer interfaces accelerating efficiency.
Segment performance and business unit highlights
Care Chemicals: Largest business, CHF 2.2 billion revenue, 19% margin, strong in cosmetics (Lucas Meyer acquisition), pharma, and mining; targeting 9% growth in pharma and double market growth in cosmetics and mining.
Lucas Meyer Cosmetics acquisition strengthens position in premium active ingredients, with double-digit growth outlook and significant synergy potential.
Catalysts: CHF 850 million sales, 18.8% EBITDA margin, global footprint, leading in petrochemicals, syngas, and specialties; leveraging digital Clarity platform and targeting growth from energy transition and hydrogen economy.
Adsorbents & Additives: CHF 1 billion revenue, 13% margin, leading in purification, flame retardants, and sustainable additives; turnaround in progress with margin recovery and focus on renewable fuels and PFAS-free solutions.
Margin recovery underway in Adsorbents & Additives, leadership in renewable fuels purification, and turnaround in additives driven by sustainability and regulatory trends.
Latest events from Clariant
- EBITDA margin rose to 17.8% in 2025, with flat sales and strong free cash flow conversion.CLN
Q4 202526 Feb 2026 - EBITDA margin before exceptional items rose to 17.9% in Q3 2025 despite lower sales.CLN
Q3 20253 Feb 2026 - EBITDA margin guidance raised to 16% as cost savings and portfolio actions drive resilience.CLN
Q2 20242 Feb 2026 - Q3 2024 sales and EBITDA fell, but cost savings and margin guidance remain robust.CLN
Q3 202418 Jan 2026 - 2024 delivered higher margins and cash flow; 2025 targets further margin gains and cost savings.CLN
Q4 202426 Dec 2025 - Q1 2025 delivered higher margins and resilient growth, with cautious guidance amid global uncertainty.CLN
Q1 202521 Dec 2025 - EBITDA margin before exceptionals rose to 17.5% in Q2 2025, despite flat sales and restructuring costs.CLN
Q2 202516 Nov 2025 - Clariant advances specialty strategy, boosts margins, and confirms 2024 outlook.CLN
Baader Helvea North America Chemical Roadshow Presentation13 Jun 2025